Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (58)

2023

  1. C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies

    European Journal of Medicinal Chemistry, Vol. 251

  2. Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging

    Antioxidants, Vol. 12, Núm. 10

  3. Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review

    Pharmaceutics, Vol. 15, Núm. 6

2022

  1. Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout

    Journal of Medicinal Chemistry, Vol. 65, Núm. 8, pp. 6250-6260

2021

  1. In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral N-Propargyl-1,2-amino Alcohol Derivatives

    Chemical Research in Toxicology, Vol. 34, Núm. 5, pp. 1245-1249

  2. The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy

    Antioxidants, Vol. 10, Núm. 7

2020

  1. Cerebral ischemia and traumatic brain injury: Protection by melatonin

    Melatonin: Production, Functions and Benefits (Nova Science Publishers, Inc.), pp. 231-255

  2. In Vitro and in Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases

    ACS Chemical Neuroscience, Vol. 11, Núm. 22, pp. 3793-3801

  3. Melatonin reduces NLRP3 inflammasome activation by increasing α7 nAChR-mediated autophagic flux

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18

  4. Melatonin's efficacy in stroke patients; a matter of dose? A systematic review

    Toxicology and Applied Pharmacology, Vol. 392

  5. Primary hippocampal estrogenic dysfunction induces synaptic proteins alteration and neuronal cell death after single and repeated paraquat exposure

    Food and Chemical Toxicology, Vol. 136

2019

  1. Differential effects of sevoflurane and propofol on swine cardiac conduction system

    Veterinary Anaesthesia and Analgesia, Vol. 46, Núm. 3, pp. 344-351

  2. Manganese induced ROS and AChE variants alteration leads to SN56 basal forebrain cholinergic neuronal loss after acute and long-term treatment

    Food and Chemical Toxicology, Vol. 125, pp. 583-594

  3. Oxidative stress and cell death induction by amitraz and its metabolite BTS-27271 mediated through cytochrome P450 and NRF2 pathway alteration in primary hippocampal cell

    Food and Chemical Toxicology, Vol. 129, pp. 87-96

  4. Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics

    Cancers, Vol. 11, Núm. 11

  5. Proteasome 20S and Rab5 Alteration after 24 h and 14 Days Chlorpyrifos Exposure Lead to β-Amyloid and Tau Protein Level Increases and SN56 Neuronal Cell Death

    Chemical Research in Toxicology, Vol. 32, Núm. 10, pp. 1920-1924

  6. Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy

    Molecules, Vol. 24, Núm. 8

  7. The emergence of melatonin in oncology: Focus on colorectal cancer

    Medicinal Research Reviews, Vol. 39, Núm. 6, pp. 2239-2285

2018

  1. How melatonin combats ischemic brain injury

    Melatonin: Medical Uses and Role in Health and Disease (Nova Science Publishers, Inc.), pp. 185-209

  2. Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases

    British Journal of Pharmacology, Vol. 175, Núm. 16, pp. 3220-3229